Yes, mutations in GPCRs can significantly impact their function and, consequently, the toxicity of certain compounds. Some mutations may lead to increased sensitivity to toxins, while others might render the receptor inactive, affecting normal physiological responses. Studying these mutations helps in understanding individual differences in susceptibility to toxins and adverse drug reactions.
